QQ客服 官方微博 反馈留言

	Plinabulin, a Novel Small Molecule in Development for Chemotherapy-Induced-Neutropenia (CIN) Prevention, Mobilizes CD34+Cells through a Mechanism of Action (MoA) Different from G-CSF and from CXCR4 Inhibition
	Blayney, Douglas W.; Ette, Ene; Ogenstad, Stephan; Shi, Yuankai; Du, Lihua; Lloyd, Kenneth; Huang, Lan; Mohanlal, Ramon
	2018
卷号	132
ISSN号	0006-4971
DOI	10.1182/blood-2018-99-113569
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6349080
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Blayney, Douglas W.,Ette, Ene,Ogenstad, Stephan,et al. Plinabulin, a Novel Small Molecule in Development for Chemotherapy-Induced-Neutropenia (CIN) Prevention, Mobilizes CD34+Cells through a Mechanism of Action (MoA) Different from G-CSF and from CXCR4 Inhibition[J],2018,132.
APA	Blayney, Douglas W..,Ette, Ene.,Ogenstad, Stephan.,Shi, Yuankai.,Du, Lihua.,...&Mohanlal, Ramon.(2018).Plinabulin, a Novel Small Molecule in Development for Chemotherapy-Induced-Neutropenia (CIN) Prevention, Mobilizes CD34+Cells through a Mechanism of Action (MoA) Different from G-CSF and from CXCR4 Inhibition.,132.
MLA	Blayney, Douglas W.,et al."Plinabulin, a Novel Small Molecule in Development for Chemotherapy-Induced-Neutropenia (CIN) Prevention, Mobilizes CD34+Cells through a Mechanism of Action (MoA) Different from G-CSF and from CXCR4 Inhibition".132(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。